Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100124 · ClinicalTrials.gov registry record · NA
MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 987
- Enrollment target
NCT02100124: Completed NA study, sponsored by Milton S. Hershey Medical Center.
NCT02100124 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 987 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02100124, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 987 participants
- Enrollment target
Study Summary
The purpose of this web-based study is to determine whether reproductive life planning (RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of unintended pregnancy when compared to an information-only control group.
Primary Outcome
Percentage of surveys with any contraceptive use
Interventions
- BEHAVIORAL Reproductive Life Planning (RLP)
- BEHAVIORAL Contraceptive Action Planning
- BEHAVIORAL Contraception information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 987 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02100124 record still lists
NCT02100124 is an interventional study that assigns participants to a tested intervention. The registered 987 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 3 interventions - of which Reproductive Life Planning (RLP) is the first listed.
NCT02100124 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02100124 about?
NCT02100124 is a clinical study titled "MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning". The purpose of this web-based study is to determine whether reproductive life planning (RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of unintended pregnancy when compared to an information-only control group.
What is the current status of trial NCT02100124?
This trial is currently completed. It is a NA study. The enrollment target is 987 participants. The study started on 2014-04. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02100124?
The interventions under investigation include: Reproductive Life Planning (RLP) (BEHAVIORAL), Contraceptive Action Planning (BEHAVIORAL), Contraception information (BEHAVIORAL).
Who is sponsoring clinical trial NCT02100124?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02100124's enrollment target sits among peer trials
987 122nd of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia